Recent case study highlights the importance of applying statistical rigor throughout the development and validation processes of biomarkers.
Elisabeth Coart, PhD
Advertisement
Articles by Elisabeth Coart, PhD
The development and qualification of biomarkers are keys to the future of drug development and precision medicine, particularly in oncology.
Advertisement
Latest Updated Articles
- Integration of Biomarker Validation in Oncology Trials
Published: August 13th 2020 | Updated:
Integration of Biomarker Validation in Clinical Development in OncologyPublished: May 28th 2020 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
2
Reducing Site Burden Through Better Technology Integration in Clinical Trials
3
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
4
Broad Survival Benefit from MATTERHORN Trial Highlights New Approach to Biomarker Use
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
